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ABSTRACT Dengue is a disease endemic in Latin American countries, like Venezu-
ela, and has become one of the most important public health problems. We report
ﬁve complete coding sequences of dengue virus serotype 2 (DENV-2) isolated from
DENV-infected patients in Venezuela. Phylogenetic analysis placed the isolates within
the American/Asian genotype.
Dengue virus (DENV) infection continues to be one of the most prevalent arboviraldiseases in tropical and subtropical regions, with an estimated burden of 390
million cases/year worldwide (1). Infection by any of the four DENV serotypes (DENV-1
to DENV-4) can lead to a wide spectrum of clinical outcomes, ranging from asymp-
tomatic cases, mild disease as a ﬂu-like syndrome (dengue without warning signs), to
a more severe form of disease (dengue with warning signs or severe dengue) (1–3).
Severe disease is frequently associated with the Asian DENV-2 and DENV-3 genotypes
with secondary infections (4). To date, there is no fully successful vaccine or speciﬁc
treatment for DENV infection (5, 6).
We report ﬁve complete coding sequences of dengue virus serotype 2 (DENV-2)
isolated from DENV-infected patients in Venezuela in 2015, of whom two patients had
dengue with warning signs. The study was approved by the ethics review committee
of the Biomedical Research Institute, Carabobo University [Aval Bioetico numbers
CBIIB(UC)-014 and CBIIB-(UC)-2013-1], Maracay, Venezuela, and the Ethics, Bioethics and
Biodiversity Committee of the National Foundation for Science, Technology and Inno-
vation, Caracas, Venezuela. For sequencing, RNA isolation was performed with the
QIAamp viral RNA isolation kit (Qiagen, Hilden, Germany). Libraries were prepared
with the TruSeq V2 RNA (Illumina, San Diego, CA, USA), which includes a cDNA
synthesis step. Sequencing was performed on a MiSeq instrument with the MiSeq
reagent kit version 2 (Illumina) that generated 150-bp paired-end reads. The
sequences were assembled and analyzed using the CLC Genomics Workbench
version 10.1.1 software (Qiagen). Genome annotation was performed using the
plugin MetaGeneMark version 1.4.
The complete open reading frame (ORF) of the DENV-2 polyprotein was obtained in
all samples with a coverage of greater than 177-fold. The lengths of the genomes
sequenced were 10,694 nucleotides (nt), 10,619 nt, 10,712 nt, 10,711 nt, and 10,704 nt,
with the lengths of the 5=/3= untranslated regions being 87/431 nt, 87/356 nt, 84/452
nt, 86/449 nt, and 77/451 nt, respectively. These are slightly shorter than the 96/451 nt
reported for the DENV-2 reference genome (GenBank accession number NC_001474).
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The phylogenetic analysis based on the complete ORF using the maximum likelihood
method revealed that the isolates belong to the American/Asian genotype. Strains
clustered in two different subpopulations, sharing a common ancestor within the
Venezuelan clade.
Molecular surveillance to monitor circulating DENV-2 strains in Venezuela is lacking
nowadays, and any information about current or past circulating strains has not been
reported since 2008 (7). The replacement of less virulent strains by the (re)emergence
of more virulent strains or in situ recombination has happened before in Venezuela;
consequently, such potential changes should be monitored to reveal evolutionary
trends (8). The sequences of DENV-2 described in this work will help follow up on the
molecular epidemiology of DENV in Venezuela. In addition, these genome sequences
add to the knowledge of the current DENV-2 diversity and endemicity, which are
important for developing future accurate vaccines.
Accession number(s). The complete coding sequences of the ﬁve DENV-2 strains
described here have been deposited in GenBank under the accession numbers MH069495
(DENV-2/VE/IDAMS/921099), MH069496 (DENV-2/VE/IDAMS/921096), MH069497 (DENV-2/
VE/IDAMS/921095), MH069498 (DENV-2/VE/IDAMS/910121), and MH069499 (DENV-2/
VE/IDAMS/910105).
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